LV12432A - Benzooksazinonu asimetriska sinteze - Google Patents

Benzooksazinonu asimetriska sinteze

Info

Publication number
LV12432A
LV12432A LV990096A LV990096A LV12432A LV 12432 A LV12432 A LV 12432A LV 990096 A LV990096 A LV 990096A LV 990096 A LV990096 A LV 990096A LV 12432 A LV12432 A LV 12432A
Authority
LV
Latvia
Prior art keywords
asymmetric synthesis
benzooxazones
cyclopropylethynyl
benzoxazin
hiv
Prior art date
Application number
LV990096A
Other languages
English (en)
Other versions
LV12432B (lv
Inventor
Michael Ernest Pierce
Anusuya Choudhury
Rodney Lawrence Parsons Jr
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of LV12432A publication Critical patent/LV12432A/lv
Publication of LV12432B publication Critical patent/LV12432B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
LVP-99-96A 1996-12-16 1999-07-30 Benzooksazinonu asimetriskā sintēze LV12432B (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3298096P 1996-12-16 1996-12-16
US08/838,838 US5932726A (en) 1996-12-16 1997-04-11 Asymmetric synthesis of benzoxazinones
PCT/US1997/022674 WO1998027073A1 (en) 1996-12-16 1997-12-15 Asymmetric synthesis of benzoxazinones

Publications (2)

Publication Number Publication Date
LV12432A true LV12432A (lv) 2000-02-20
LV12432B LV12432B (lv) 2000-07-20

Family

ID=26709131

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-96A LV12432B (lv) 1996-12-16 1999-07-30 Benzooksazinonu asimetriskā sintēze

Country Status (27)

Country Link
US (1) US5932726A (lv)
EP (1) EP0944610B1 (lv)
JP (1) JP4232911B2 (lv)
KR (1) KR100498665B1 (lv)
CN (1) CN1075063C (lv)
AT (1) ATE289296T1 (lv)
AU (1) AU750047B2 (lv)
BR (1) BR9714031A (lv)
CA (1) CA2275323C (lv)
CZ (1) CZ297168B6 (lv)
DE (1) DE69732525T2 (lv)
EA (1) EA002987B1 (lv)
EE (1) EE03920B1 (lv)
ES (1) ES2235265T3 (lv)
HR (1) HRP970688A2 (lv)
HU (1) HU225655B1 (lv)
IL (2) IL130684A (lv)
LV (1) LV12432B (lv)
NO (1) NO313236B1 (lv)
NZ (1) NZ336163A (lv)
PL (1) PL192661B1 (lv)
PT (1) PT944610E (lv)
RO (1) RO120844B1 (lv)
SI (1) SI20071A (lv)
SK (1) SK285258B6 (lv)
UA (1) UA66773C2 (lv)
WO (1) WO1998027073A1 (lv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
TWI326283B (en) * 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
EP1614672B1 (en) * 2003-04-04 2010-09-22 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
EP2313379B1 (en) * 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2441759A1 (en) * 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447255A1 (en) * 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
EP2944631A1 (en) * 2014-05-12 2015-11-18 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of Efavirenz
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
KR102644663B1 (ko) * 2015-12-08 2024-03-07 디아이씨 가부시끼가이샤 옥사진 화합물, 조성물 및 경화물
KR102644662B1 (ko) * 2015-12-08 2024-03-07 디아이씨 가부시끼가이샤 옥사진 화합물, 조성물 및 경화물
JP6268565B2 (ja) * 2015-12-08 2018-01-31 Dic株式会社 オキサジン化合物、組成物及び硬化物
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE343057C (de) * 1914-06-21 1921-10-25 Kalle & Co Aktien Ges Verfahren zur Darstellung von 1-Arylamino-4-oxynaphthalinen
US3280120A (en) * 1964-03-09 1966-10-18 Rexall Drug Chemical Substituted benzoxazines, process therefor and intermediates
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3513166A (en) * 1967-05-22 1970-05-19 Robins Co Inc A H 3-(omega-aminoalkyl)-4-substituted-1,3-benzoxazine-2-ones
AU5960380A (en) * 1979-08-30 1981-03-05 A. Ehrenreich G.m.b.H. & Co. KG Bellows seal and retaining ring
DE3622262A1 (de) * 1986-07-02 1988-01-07 Bayer Ag Chromogene 3,1-benzoxazine
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Also Published As

Publication number Publication date
NO992914D0 (no) 1999-06-15
HRP970688A2 (en) 1998-10-31
CN1075063C (zh) 2001-11-21
SK80399A3 (en) 2000-03-13
CZ297168B6 (cs) 2006-09-13
KR20000057574A (ko) 2000-09-25
AU5694498A (en) 1998-07-15
PL334281A1 (en) 2000-02-14
PT944610E (pt) 2005-04-29
UA66773C2 (uk) 2004-06-15
EP0944610A1 (en) 1999-09-29
HUP0000168A2 (hu) 2000-09-28
CA2275323A1 (en) 1998-06-25
JP2001507684A (ja) 2001-06-12
NZ336163A (en) 2001-04-27
ES2235265T3 (es) 2005-07-01
SI20071A (sl) 2000-04-30
NO992914L (no) 1999-06-15
JP4232911B2 (ja) 2009-03-04
ATE289296T1 (de) 2005-03-15
EA002987B1 (ru) 2002-12-26
DE69732525T2 (de) 2006-01-12
US5932726A (en) 1999-08-03
CN1245493A (zh) 2000-02-23
HUP0000168A3 (en) 2001-02-28
SK285258B6 (sk) 2006-10-05
AU750047B2 (en) 2002-07-11
BR9714031A (pt) 2000-05-09
HU225655B1 (en) 2007-05-29
PL192661B1 (pl) 2006-11-30
LV12432B (lv) 2000-07-20
NO313236B1 (no) 2002-09-02
RO120844B1 (ro) 2006-08-30
EE9900243A (et) 1999-12-15
WO1998027073A8 (en) 1999-11-04
IL130684A0 (en) 2000-06-01
KR100498665B1 (ko) 2005-07-01
CA2275323C (en) 2003-04-08
EE03920B1 (et) 2002-12-16
CZ212899A3 (cs) 1999-11-17
EA199900552A1 (ru) 2000-02-28
WO1998027073A1 (en) 1998-06-25
IL130684A (en) 2003-12-10
DE69732525D1 (de) 2005-03-24
EP0944610B1 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
LV12430A (lv) Slapekli saturosi heteroaromatiski savienojumi ka xa faktora inhibitori
LV12432A (lv) Benzooksazinonu asimetriska sinteze
DK0828703T3 (da) Asymmetrisk syntese af (-)-6-chlor-4-cyclopropylethynyl-4-trifluormethyl-1,4-dihydro-2H-3,1-benzoxazin-2-on
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
YU3696A (sh) Poboljšana sinteza ciklopropilacetilena
DK1052250T3 (da) Sulfonylalkanoylamino-hydroxyethylamino-sulfonamider som inhibitorer af retroviral protease
ATE248826T1 (de) 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv- reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
EA199900907A1 (ru) 4,4-дизамещенные 3,4-дигидро-2(1н)-хиназолиноны, полезные в качестве ингибиторов обратной транскриптазы вич
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
IS6859A (is) Kristölluð form atorvastatíns
BR9808486A (pt) Processo para a preparação de um composto
EA200200471A1 (ru) Конденсированные нафтиридины в качестве ингибиторов обратной транскриптазы вич
PT766668E (pt) Processos para a preparacao de formas anidras e hidratadas de derivados antihistaminicos da piperidina e de polimorfos e pseudomorfos destes
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
BR9809111A (pt) Novos intermediários e processo para sua preparação
TR200402779T4 (tr) Benzotiyofen türevi bileşikler, bunların hazırlama yöntemleri ve kullanımları.
DE69808619T2 (de) Prostaglandin-pharmazeutische-zusammensetzungen
ES2184304T3 (es) Procedimiento de preparacion de un perhidro-isoindol sustituido.
TW200621735A (en) Synthesis of a benzoxazinone
DK0892801T3 (da) Acridon-afledte forbindelser, der er anvendelige som antineoplastiske og antiretrovirale midler
DK0804410T3 (da) Fremgangsmåde til fremstilling af retrovirale proteaseinhibitor-mellemprodukter
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
CY1105338T1 (el) Διαδικασια για την παρασκευη δισκοδepμολιδης και αναλογων αυτης
NO995676D0 (no) Isoftalamid derivat som gul polymorf
GT199900047A (es) Procedimiento para alquilar sulfonamidas impedidas estèricamente.